These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3177241)

  • 1. Usefulness of dipyridamole-thallium-201 perfusion scanning for distinguishing ischemic from nonischemic cardiomyopathy.
    Eichhorn EJ; Kosinski EJ; Lewis SM; Hill TC; Emond LH; Leland OS
    Am J Cardiol; 1988 Nov; 62(13):945-51. PubMed ID: 3177241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy.
    Glamann DB; Lange RA; Corbett JR; Hillis LD
    Arch Intern Med; 1992 Apr; 152(4):769-72. PubMed ID: 1558434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radionuclide imaging after coronary vasodilation: myocardial scintigraphy with thallium-201 and radionuclide angiography after administration of dipyridamole.
    Sochor H; Pachinger O; Ogris E; Probst P; Kaindl F
    Eur Heart J; 1984 Jun; 5(6):500-9. PubMed ID: 6745292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doppler and two-dimensional echocardiographic assessment of left ventricular function before and after intravenous dipyridamole stress testing for detection of coronary artery disease.
    Labovitz AJ; Pearson AC; Chaitman BR
    Am J Cardiol; 1988 Dec; 62(17):1180-5. PubMed ID: 3195479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of viable myocardium by quantitative dipyridamole-thallium-201 scintigraphy and radionuclide ventriculography.
    Zarich SW; Kowalchuk GJ; Hill T; Kosinski EJ; Lewis SM
    Chest; 1995 Feb; 107(2):335-40. PubMed ID: 7842757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction.
    Chikamori T; Doi YL; Yonezawa Y; Yamada M; Seo H; Ozawa T
    Am J Cardiol; 1992 Mar; 69(6):650-3. PubMed ID: 1536115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic indices of myocardial dysfunction correlate with dipyridamole thallium-201 SPECT.
    Chin BB; Moshin J; Bouchard M; Berlin JA; Araujo LI; Alavi A
    J Nucl Med; 1996 May; 37(5):723-9. PubMed ID: 8965134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: differences between patients with primary cardiomyopathy, chronic coronary artery disease, or acute myocardial infarction.
    Iskandrian AS; Hakki AH; Kane S
    Am Heart J; 1986 Apr; 111(4):760-7. PubMed ID: 3953400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional echocardiographic evaluation of ventricular asynergy induced by dipyridamole: correlation with thallium scanning.
    Ferrara N; Bonaduce D; Leosco D; Longobardi G; Abete P; Morgano G; Salvatore M; Rengo F
    Clin Cardiol; 1986 Sep; 9(9):437-42. PubMed ID: 3757318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the dipyridamole test on left ventricular function in coronary artery disease.
    Klein HO; Ninio R; Eliyahu S; Bakst A; Levi A; Dean H; Oren V; Beker B; Kaplinsky E; Gilboa S
    Am J Cardiol; 1992 Feb; 69(5):482-8. PubMed ID: 1736611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative relationship between global left ventricular thallium uptake and blood flow: effects of propranolol, ouabain, dipyridamole, and coronary artery occlusion.
    Melin JA; Becker LC
    J Nucl Med; 1986 May; 27(5):641-52. PubMed ID: 3012029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole magnetic resonance imaging: a comparison with thallium-201 emission tomography.
    Pennell DJ; Underwood SR; Ell PJ; Swanton RH; Walker JM; Longmore DB
    Br Heart J; 1990 Dec; 64(6):362-9. PubMed ID: 2271342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis.
    Tellier P; Paycha F; Antony I; Nitenberg A; Valeyre D; Foult JM; Battesti JP
    Am J Med; 1988 Aug; 85(2):189-93. PubMed ID: 3400694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
    La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
    Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of intravenous dipyridamole thallium scintigraphy after an acute myocardial ischemic event.
    Younis LT; Byers S; Shaw L; Barth G; Goodgold H; Chaitman BR
    Am J Cardiol; 1989 Jul; 64(3):161-6. PubMed ID: 2741825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgery.
    Lette J; Waters D; Lapointe J; Gagnon A; Picard M; Cerino M; Kerouac M
    Am J Cardiol; 1989 Aug; 64(5):276-81. PubMed ID: 2756871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction.
    Cuocolo A; Acampa W; Nicolai E; Pace L; Petretta M; Salvatore M
    J Nucl Cardiol; 2000; 7(1):8-15. PubMed ID: 10698229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of late cardiac events by dipyridamole thallium scintigraphy in patients with intermittent claudication and occult coronary artery disease.
    Darbar D; Gillespie N; Main G; Bridges AB; Kennedy NS; Pringle TH; McNeill GP
    Am J Cardiol; 1996 Oct; 78(7):736-40. PubMed ID: 8857474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verification of the left ventricular ejection fraction from gated myocardial perfusion studies (GSPECT).
    Teresińska A; Wnuk J; Konieczna S; Dabrowski A
    Kardiol Pol; 2005 Nov; 63(5):465-75; discussion 476-7. PubMed ID: 16362849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of myocardial ischemia in Kawasaki disease: thallium-201 myocardial imagings at rest, with exercise and with dipyridamole administration].
    Mitomori T; Ono Y; Sugiyama H; Suzuki A; Kamiya T; Nishimura T; Kozuka T
    J Cardiogr; 1984 Jun; 14(1):59-73. PubMed ID: 6520427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.